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Abstract
Advancement in electrophoresis and mass spectrometry techniques along with the recent progresses in genomics, culminating in
bovine and pig genome sequencing, widened the potential application of proteomics in the field of veterinary medicine. The aim of
the present review is to provide an in-depth perspective about the application of proteomics to animal disease pathogenesis, as
well as its utilization in veterinary diagnostics. After an overview on the various proteomic techniques that are currently applied to
veterinary sciences, the article focuses on proteomic approaches to animal disease pathogenesis. Included as well are recent
achievements in immunoproteomics (ie, the identifications through proteomic techniques of antigen involved in immune
response) and histoproteomics (ie, the application of proteomics in tissue processed for immunohistochemistry). Finally, the article
focuses on clinical proteomics (ie, the application of proteomics to the identification of new biomarkers of animal diseases).
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Historical Perspective
In the last few years, there has been an awakening interest in
using proteomics and the complementary, essential advances
in bioinformatics, to address problems of veterinary pathogen-
esis. However, the application of proteomics in veterinary med-
icine has been limited in comparison to studies that have
explored the potential of these advanced protein-analytic tech-
nologies in human clinical medicine. Historically, analysis of
serum protein has been an essential part of the armory of veter-
inary diagnostic investigations for disease pathogenesis but has
been limited to measurement of total protein, albumin, globu-
lin, and albumin: globulin ratio and serum protein electrophor-
esis (SPE) on agarose.39 The latter method separates serum into
around 8 fractions from albumin to the g-globulin fraction, but
the protein bands seen on SPE hide a multitude of proteins that,
if identified46 and measured with valid procedures, could pro-
vide a treasure trove of pathologic and diagnostic biomarkers.6
Proteomics holds the key to unlocking this vision of advancing
veterinary pathology and diagnostics.
Although the application of proteomics in veterinary
medicine has lagged behind human medical uses, there has
been increased activity recently, especially for investigation
of farm animal health and disease.42 A number of relevant
and informative reviews have appeared12,38,39,41,53 that lay
the groundwork for further participation of veterinary
laboratories in this exciting and rapidly advancing field. In
this review, we look at the current uses of proteomics in
veterinary medicine with particular emphasis on infectious
disease, pathogenesis, and diagnostics.
Proteomic Techniques
The term proteomics refers to the large-scale study of proteins,
including their structures and functions, whereas proteome can
be defined as the set of proteins expressed by the genetic mate-
rial of an organism under defined environmental conditions.99
Proteomics has emerged as a field of research in less than 2
decades108 and has developed rapidly, driven by improvements
in technology and by the need for analytic approaches that can
deliver global protein characterization. The ability to sequence
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entire genomes and to collate the resulting data into genome
sequences has enabled proteomics, but the global characterization
of the proteins that compose even relatively simple biological sys-
tems is still not achievable.21 A proteome is generally more com-
plex than the encoding genome, and the proteins are present
across a broad dynamic range.31 These issues are compounded
by regulation of protein expression, in response to developmental
and environmental stimuli, which results in a dynamic proteome.
Nevertheless, the importance of proteins as the primary effector
molecules of biology, which are also the major drug targets and
antigens, has promoted strong interest and investment in proteo-
mics, and the field continues to develop rapidly.
Proteomics involves the resolution of a complex mixture of
proteins into components that can then be characterized. Char-
acterization always involves matching protein to encoding
gene (identification) but can also involve relative quantitation
or further characterization to reveal posttranslational protein
modification. Protein characterization is performed by mass
spectrometers, which are generally fed proteins after some ini-
tial fractionation. The type of fractionation employed is deter-
mined by the complexity of the proteome and by the specific
research question but must be compatible with the downstream
mass spectrometry (MS). Currently, 2 major MS platforms are
employed for proteomics, differentiated by the mechanism
through which ions are generated: these ion sources are termed
matrix-assisted laser desorption/ionization (MALDI) and elec-
trospray ionization (ESI). MALDI instruments receive analytes
in the solid state, while the sample is delivered to ESI instru-
ments in a volatile solvent. These different platforms have
advantages and disadvantages but are complementary, and
most proteomics labs will operate both systems. Whatever the
MS system that is used, the optimum goal is to deliver peptides
as homogeneous populations that can be characterized without
competition from other species, such as different peptides,
other polymers, or salts. Given that even simple prokaryote
proteomes comprise thousands of proteins and multicellular
species may comprise greater than 100 000 proteins, this is a
tall order and requires extensive sample fractionation.
The protein fractionation systems that are employed in proteo-
mics are either electrophoretic or chromatographic: the former is
typically applied to intact proteins and the latter to peptides gener-
ated by protein cleavage. Orthogonal separation approaches are
often utilized to enhance resolution, and the archetypal orthogonal
separation in proteomics is 2-dimensional electrophoresis (2DE).48
Conventional 2DE involves separation by isoelectric focusing in
the first dimension, followed by sodium dodecyl sulphate electro-
phoresis in the second. Both dimensions are performed in a polya-
crylamide gel matrix, and the proteins migrate on 2-dimensional
gels as spots according to isoelectric point and apparent molecular
weight. The resulting spot map, which can be visualized by protein
staining, can resolve several thousand protein species, and spots
can be excised directly from the gel for characterization by MS.
2DE is a powerful approach for descriptive and comparative
proteome analysis, as it remains the highest-resolution protein
separation approach and is inherently quantitative. The separa-
tion of intact proteins by charge and mass can highlight
posttranslational modifications that would not be evident in 1-
dimensional electrophoresis or in peptide-based separations.96
2DE tends to underrepresent some classes of protein, including
those that are of relatively low abundance, very large, or highly
charged. Some of these issues can be circumvented by prefrac-
tionation to enrich proteins of interest or by focusing 2DE on
specific charge and/or mass ranges. Very hydrophobic proteins
may be refractory to solubilization in the nonionic conditions
that are required for isoelectric focusing, and alternative deter-
gents or 2-dimensional separations, such as the BAC/SDS-
PAGE system,18,51 have proven useful in this context. Neverthe-
less, 2DE is often considered a time-consuming and technically
challenging approach that has limited advantages over more
readily automated chromatographic methods.
The heterogeneity of intact proteins, which is exploited in
2DE, limits the resolution of chromatography for proteomic
workflows. Instead, proteins are typically fragmented to peptides
before chromatographic separation. Reversed-phase chromato-
graphic separation of peptides is ideally suited to proteomics
because peptides can be trapped and desalted before elution and
because the mobile phase comprises volatile solvents that can be
evaporated in the ESI source. Chromatography can thus be
directly coupled to ESI-MS, facilitating automation and mini-
mizing sample loss. Multidimensional chromatographic separa-
tion is increasingly employed117 because it can be automated and
because even highly charged or hydrophobic proteins will likely
generate some peptides that are amenable to MS analysis. Ion
exchange is mostly used as a first dimension, giving separation
based on orthogonal biophysical characteristics to reversed-
phase chromatography and taking advantage of the latter to
desalt ion exchange fractions before MS. Chromatographic
approaches can be more sensitive than electrophoresis because
there is no requirement to recover proteins or peptides from a gel
matrix. However, the conversion of each protein in an already
complex proteome to a large number of peptides is counterpro-
ductive when the goal is to maximize proteomic coverage,
because there are limits to the resolution of multidimensional
peptide chromatography, so prefractionation or proteomic mate-
rial is often important. Combinations of electrophoresis and
chromatography are among the most efficient fractionation sys-
tems,116 but targeted approaches such as subcellular fractiona-
tion or affinity purification of protein complexes can result in
greatly enhanced coverage of a subproteome.
Typically, proteins will be obtained from a biological source
and fractionated by electrophoresis. Protein fractions will then be
trypsinized to generate peptides that can be further fractionated
by high-performance liquid chromatography (LC) before analysis
by an ESI-MS that is fed directly with the chromatography eluate
(LC-MS). The MS will generally be capable of recording the mass
of analytes and able to isolate and fragment peptide ions (MS/MS,
or tandem MS) to generate information about structure.21 The
resulting data are fed to a search engine, such as Mascot (Matrix
Science Ltd), which generates in silico MS data for the specified
genome sequence database and looks for statistically significant
matches with the experimentally generated MS data. The data out-
put is typically a list of potential matches, ranked by confidence, to
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proteins that may be components of the sample. It is important to
recognize that this will not be a complete list of protein compo-
nents, largely because some will be present at levels below the
threshold of detection but also because some proteins are refractory
to analysis or are not represented in the genome database. It is also a
qualitative data set, but quantitative data are often desirable.
Absolute protein quantitation is difficult to undertake in an
-omic context, but relative quantitation can be achieved by a
diversity of comparative approaches. Relative quantitation of
intact proteins is generally performed by gel-based methods,
such as 2DE using semiquantitative protein stains, or protein-
labeling strategies, such as difference gel electrophoresis
(DiGE).3 The advent of DiGE technology has greatly enhanced
the utility of 2DE for quantitative proteomic analysis, enabling
the direct comparison on a single gel of samples that are differ-
entially labeled by fluorophores that are mass and charged
matched but spectrally discrete. For example, DiGE has been
exploited to reveal changes in the expression of discrete iso-
forms of tryparedoxin peroxidase in virulent and attenuated
strains of Leishmania.34 Quantitation at the peptide level can
be achieved by stable isotope-labeling approaches or by label-
free comparison. Isolated proteins or tryptic peptides can be che-
mically labeled before separation [iTRAQ]97, dimethyl label-
ing,58 and a plethora of other approaches,21 or proteins can be
metabolically labeled with heavy and light amino acids (stable
isotope labeling with amino acids in culture [SILAC]).89 All
these labeling approaches involve mixing of samples for com-
parison after labeling but before separation and MS analysis.
The relative abundance of specific proteins in each sample is
deconvoluted from the resulting MS data, using appropriate
software. Of the protein-labeling approaches, SILAC is attrac-
tive because label is incorporated during growth, avoiding the
possibility of introducing artifactual changes in protein abun-
dance during the sample preparation step. However, SILAC
labeling can be performed only in biological systems that are
auxotrophic for the amino acids that are supplied as labels, while
chemical labeling of proteins can be performed with proteins
from any source.
Label-free approaches, which involve serial LC-MS analy-
sis of multiple unlabeled samples, are becoming commonplace
as the robustness of chromatographic separation improves and
facilitates the alignment of data sets that is essential for
comparison. Label-free approaches are more costly in instru-
ment time, as unlabeled samples cannot be multiplexed—an
important consideration, as LC-MS instrumentation is costly
to maintain. Regardless of the quantitation approach, compara-
tive proteomics experiments have the potential to highlight
key proteins in phenotypes of interest20 and thus have tremen-
dous potential to highlight drug targets and biomarkers and
elucidate biological mechanisms.
Proteomic Approaches to Animal Disease
Pathogenesis
Several proteomic techniques have been applied so far to the
understanding of dynamic protein pathways involved in host
and pathogen responses during diseases. Pathogens and
immune defenses adapt to each other. This adaptation is due
to the regulation of the expression of several genes of both
sides, to changing stimuli. This capability to fine-tune gene
expression can and has been studied by DNA microarray tech-
niques, in particular for what concerns the microbiome (ie, the
pathogen component).88 However, since the correlation
between DNA levels and actual protein expression is poor,50
integration between the 2 techniques, genomics and prote-
omics, is required.
Proteomics Research in Bovine Species: Focus on Mastitis
and Respiratory Diseases
Mastitis is considered the most frequent and most costly pro-
duction disease in dairy cows. It is therefore not surprising that
proteomics has been widely applied to investigate mastitis
pathogenesis. Intramammary infections with Staphylococcus
aureus and Escherichia coli have received a lot of attention due
to their economic impact. In the classical experiment of Boeh-
mer and coworkers,13 acute mastitis was induced by infection
with E. coli in a group of dairy cows, whereas another group
was treated with sterile physiologic solution. 2DE gel electro-
phoresis was carried out before and 18 hours after the infection,
and differentially expressed proteins were identified in milk by
peptide sequencing with MALDI time of flight (TOF). Intra-
mammary infection caused by S. aureus was also investi-
gated.63 Three strains were used, and proteomic analysis
revealed that while acute phase protein expression was almost
identical, differential regulation of strain-specific host IFN-g
and antimicrobial peptides were observed. A similar experi-
mental design was applied after challenging the mammary
gland with bacteria-derived pathogen-associated molecules,
such as E. coli lipopolysaccharide and S. aureus lipoteichoic
acid.56 Proteomic analysis was carried out on milk, revealing
in both groups of animals an almost complete hydrolysis of
casein, supposedly caused by an overexpression of proteases.
The results obtained during these experiments also identified
useful candidates for biomarker identification (Table 1). The
importance of proteomics (and peptidomics in particular) in
new biomarker search has been clearly evidenced in a recent
publication, focused on peptidomics investigation during
mastitis.77 Another remarkable study demonstrated how a- and
b-caseins modulate biofilm formation during mastitis of
Streptococcus uberis.112 This activity is increased by casein
degradation, which can be induced by bacterial proteases.
Prerequisite of these ‘‘pathogenesis-focused’’ studies are
preliminary experiments aimed at elucidating the mammary
gland immunoproteome, identifying the proteins that are
responsible, in physiologic status, for immune defense of the
mammary gland in milk55 and in mammary parenchyma.11
Proteomic techniques were useful to explore other bovine
major disease groups, such as those involving respiratory appa-
ratus. Bronco alveolar lavage fluid represents an ideal speci-
men for proteomic analysis. 2DE proteomics confirmed the
importance of stressors, such as transportation and weaning,
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in respiratory disease development.83 Broncho alveolar fluid
was also studied by LC-MS/MS following experimental induc-
tion of pneumonia with Mannheimia haemolytica.14 Antimi-
crobial peptides and acute phase proteins were identified by
proteomics as being upregulated in bovine mucosal defense.
Proteomic Approaches to Parasitosis in Small Ruminants
Most proteomic research on small ruminant species has been
focused on sheep parasites. Pathogenesis of gastrointestinal
nematode infection was recently studied by quantitatively
investigating the expression of proteins by abomasal mucosa
of resistant and susceptible sheep breed after experimental
Haemoncus contortus infection.86 A number of proteins
(4468 in total) were identified and several of them (n ¼ 158)
were found to be differentially expressed between resistant and
susceptible sheep. Proteins such as galectin-4, trefoil factor 2,
fibrillin-2, and DAG were detected in luminal mucus of resis-
tant sheep, where they can interfere with parasite adhesion pro-
cesses. Immune response to other abomasal parasites, such as
Teladorsagia circumcincta, was thoroughly explored by com-
bining 2DE and MALDI-TOF proteomics, after in vivo92 and
in vitro7 experimental infection, identifying galectin-15 as
being involved in specific resistance against parasite infection.
Both these studies focused on the abomasal mucosal surface,
going in-depth through the network of proteins that directly
interact with Teladorsagia. Epithelial cell lysates revealed
obvious candidates, such as immunoglobulin A and sheep mast
cell protease 1, and less obvious ones, such as calcium-
activated chloride channel and intelectins. The latter may be
involved in increased mucus secretion, which in turn may result
in reduced parasite infection. In a further attempt to better
define the pathogenesis of this parasite, proteomic analysis of
lymphatic drainage obtained from cannulated abomasal lymph
nodes identified other proteins, including hemopexin, a1-b
glycoprotein, and gelsolin, as being altered after Teladorsagia
infection.47 The involvement of the immune and inflammatory
defense mechanisms in Echinococcus granulosus was evi-
denced after proteomics investigation on hydatid cyst fluid, not
only from sheep, but also from cattle and humans.8 Out of 130
proteins identified from fertile cysts, only one third (n ¼ 48)
were of parasite origin, whereas the others (n ¼ 82) were from
host origin, clearly demonstrating how E. granulosus can
absorb host proteins across its outer germinal layer and deceive
the host immune system.
Proteomics Research in Pigs: Respiratory and Intestinal
Diseases
The pathogenesis of several viral diseases, including porcine
reproductive and respiratory syndrome, classical swine fever
(CSF) and porcine circovirus diseases, has been explored by
proteomics. In vitro infection of susceptible cells, such as por-
cine alveolar macrophages and Marc-145 cells,37 provided
valuable information about which cellular pathways are mostly
activated during porcine reproductive and respiratory syn-
drome viral replication, assembly, and pathogenesis. In partic-
ular, stress proteins may be involved in all stages of the life
cycle of the virus, and all the proteomics studies carried out
so far have identified heat shock proteins (HSPs), such as
HSP27 and HSP8, as well as proteins related to cytoskeleton
assembly, including annexins, b-actin, and tubulin, as being
incorporated into virion particles.
Another important swine viral disease is CSF. This virus targets
endothelial cells, and widespread hemorrhages are the pathogno-
monic clinical signs of the disease. The pathogenesis of CSF was
therefore explored by proteomics on primary porcine endothelial
cells,74 revealing that CSF virus induced a downregulation of pro-
teins involved in energy metabolism and upregulation of others
that inhibit endothelial cell proliferation. Upregulation of proteins
involved in inflammatory reaction and oxidative stress was also
demonstrated, partially elucidating the molecular bases of
endothelial damage and related vascular permeability. Further
Table 1. Application of Proteomics to New Biomarker Investigation
in Domestic Animal Disease.
Biological Specimen
Cow
Subclinical and clinical mastitis111 Serum
Stress80 Serum
Mastitis4 Serum/whey
Staphylococcus aureus mastitis63 Serum/milk
Escherichia coli and S. aureus mastitits61 Milk
Lipopolysaccharide-mediated mastitis36 Milk
Subclinical mycobacterial infection101 Serum
Bovine respiratory disease2 Serum
Clinical mastitis57 Whey
Pig
Porcine reproductive and respiratory
syndrome45
Serum
Food and mouth76 Serum
Classical swine fever104 Serum
Stress79 Serum
Peritonitis-induced sepsis109 Serum
Small ruminants
Paratubercolosis120 Serum
Horse
Chronic equine laminitis103 Serum
Osteoarthritis and osteochondritis27 Synovial fluid
Doping10 Serum
Spontaneous equine recurrent uveitis122 Serum
Dogs
European adder bite91 Urine
Meningoencephalitis87 Cerebrospinal fluid
Progressive glomerular disease85 Urine
Hemangiosarcoma64 Serum
Leishmaniosis19 Serum
Lymphoma94 Serum
Idiopathic pulmonary fibrosis75 Bronchoalveolar fluid
Cancer36 Tears
Weight loss program110 Serum
Cats
Azotemia62 Urine
Urinary tract diseases71 Urine
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progress on the knowledge of CSF pathogenesis was obtained by
proteomic characterization of macrophages involved in the devel-
opment of the disease. Both alveolar macrophages121 and periph-
eral blood monocytes104 were studied, revealing that HSP
expression was altered, as well as proteins involved in energy
metabolism, adhesion, oxidative stress, and protein translation and
processing.
Postweaning multisystemic wasting syndrome, caused by
porcine circovirus-2, was analyzed after macrophage infection,26
revealing the involvement of cytoskeletal proteins. Immune sys-
tem targeting of porcine circovirus was also explored by quanti-
tative proteomics on lymph nodes from experimentally infected
piglets, identifying acute inflammatory response-related proteins
involved in the insurgency of the disease and others involved in
oxidative stress. CD81, which has been already shown to be
involved in other viral infections, was upregulated as well.
Pigs are asymptomatic carriers of Salmonella typhimurium,
which is regarded as one of the most frequent food-borne
pathogens, transmitted through contaminated pork meat. In
vivo experimental infection, followed by DiGE and MALDI-
TOF MS of mesenteric pig lymph nodes,81 identified a complex
interaction between Salmonella and the pig immune system,
revealing an activation of pyroptosis, an innate immune mech-
anism against intracellular bacteria. By integrating high-
throughput proteomics with classical immunohistochemistry and
molecular biology, this study described at the molecular level the
delicate equilibrium between the host immune system and bac-
teria invasion. Salmonella could reduce the apoptosis rate of
neutrophils, allowing a better control of the disease, meanwhile
modulating some cell functions, such as cytoskeleton rearrange-
ment, for the benefit of the bacteria themselves.
Proteomics in Horses: Articular Disorders and Equine
Recurrent Uveitis
The application of proteomics in equine disease is not exten-
sive at present. However, 2 major horse diseases have been
studied by proteomics: osteoarthritis/osteochondrosis and
equine recurrent uveitis.
Proteomic studies were carried out on articular cartilage
inflammation in an ex vivo experimental model, providing an
in-depth perspective on the molecular pathogenesis of equine
arthritis and demonstrating how treatment with IL-1 modulates
the expression of matrix metalloproteinase-1 and -3 but
decreases, for example, that of clusterin.29
An excellent example of how classical histochemistry can
be integrated with proteomic techniques is observed in a study
focused on equine recurrent uveitis. In a label-free LC-MS/MS
analysis of vitreus from uveitis, beside an increase in comple-
ment cascade-involved proteins, a significant decrease of pro-
teins involved in Wnt signaling (ie, DKK3 and SFRP2) was
recently detected.52 Western blotting analysis allowed the
quantification of the different expression of the 2 proteins,
whereas immunohistochemistry integrated proteomics results
by locating the expression of the 2 proteins on retinal speci-
mens. Major immunohistochemical findings include a specific
downregulation of SFRP2 in retinal outer limiting membrane
and a general decrease of DKK3, which was shown to coloca-
lize with Mu¨ller glial cells. Therefore, by coupling proteomics,
quantitative Western blotting, and immunohistochemistry, this
study not only demonstrated the involvement of the Wnt path-
way in equine uveitis but also localized it at tissue levels where
the expression pattern of these proteins is mostly modified.
Proteomics in Companion Animal Disease Pathogenesis
While there have been applications in veterinary medicine
where proteomic approaches have been employed for investi-
gations in small animals and in studies of infectious and neo-
plastic disease in particular,41,53 the use of proteomics in the
study of pathogenesis in companion animals is less extensive
than that for farm animals.
Proteomics has been used in an attempt to identify novel
antigens from Leishmania chagasi for vaccine production and
diagnostic development.32 Based on DiGE and Western blot-
ting, 25 proteins from L. chagasi have been identified for use
in serum diagnostics and for consideration of vaccine develop-
ment targets. Others important dog parasites that were investi-
gated though proteomics include Ancylostoma canum84 and
Echinococcus multicularis.68
Proteomics has also been used to investigate bacterial patho-
gens of dogs and their interaction with the host. Surface proteomic
analysis has been used to identify proteins of Staphylococcus
pseudintermedius involved with adherence to the external
matrix.9 Lipoprotein from Ehrlichia chaffeenis, identified by
LC-MS/MS, was subsequently shown to elicit an immune
response in dogs.59 The response of protein in the mitochondria
of liver from dogs treated with bacterially derived lipopolysac-
charide has been studied by 2DE, with 14 of the 500 identified
proteins being shown to be differently expressed within 4 hours
of intravenous lipopolysaccharide treatment.33 Canine liver has
also been examined in bull terriers with a genetic disorder leading
to inherited lethal acrodermatitis.49
Worth mentioning is an interesting study on rabies. Three
areas of the central nervous system of dogs infected with rabies
virus resulting in paralytic or furious manifestation of the dis-
ease have been compared by 2DE, followed by quadrupole
TOF MS.108 A total of 32 proteins were found to differ in the
hippocampus, 49 in the brainstem, and 67 in the spinal cord.
In comparing the paralytic to the furious forms of the disease,
13, 17, and 41 proteins differed in the hippocampus, brainstem,
and spinal cord, respectively. The functions of the proteins
were from a range of activity, including antioxidants, HSPs,
metabolism, and transcription and translation proteins, with the
results leading to an increase in understanding the molecular
pathology and differential manifestation of the rabies in its
different forms.
As in human medicine, initiatives have been taken in canine
oncology to identify biomarkers of neoplastic disease with the use
of proteomics.38,54 Lymph nodes from dogs with B-cell lym-
phoma have been studied using 2DE and MALDI-TOF MS in
comparison to lymph nodes of healthy dogs.82 Over 90
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differentially expressed protein spots were identified, among
which proline dipeptidase, triosophosphate isomerase, and
glutathione-S-transferase were downregulated and macrophage
capping protein was upregulated in the samples from the lym-
phoma cases. While 2DE can identify differences in expression
between diseased and healthy samples, for a diagnostic test to be
based on such results requires extensive development. An
approach that held promise from human medicine to identify bio-
markers is surface-enhanced laser desorption/ionization MS.94
The advances made in proteomic science can be used to reexamine
established methods of veterinary diagnostics, and in the clinical
investigation of lymphoma, SPE is a regularly used tool in which
the proteins of serum are separated into well-known fractions,
namely, albumina1,a2,b1,b2, andg. The protein bands of agarose
SPE have been identified as a source of protein for trypsin diges-
tion and tandem mass fingerprinting. Thus the main SPE protein
bands in serum of cats with and without lymphoma, have been sub-
jected to proteomic analysis.45 The study confirmed established
understanding of the content of the main bands but also revealed
the presence of lower-abundance protein in particular fractions,
such as inter-a (globulin) inhibitor 4 in the a2 band of cats with
lymphoma.
Other neoplastic diseases that have been investigated by
proteomics include prostate and bladder carcinomas, which
have been examined by DiGE in comparison to healthy tis-
sues.72 Analysis by DiGE has also been used to investigate the
proteins of metastatic canine mammary carcinomas65 and
identified 21 proteins that were either up- or downregulated
in the carcinomas. Proteomics was also very useful in mam-
mary carcinoma66 staging, identifying individual proteins as
markers of each stage. In the first stage, named adenoma pat-
tern, phosphoglycerate mutase 1 was increased and calumenin
decreased; in the next, carcinoma pattern, 14-3-3-zeta was
increased and gelsolin decreased; and in a metastasis pattern,
bomapin was increased and maspin decreased. DiGE has also
been used to compare high-grade canine cutaneous mast cell
tumors that have poor prognosis with low-grade tumors with
better prognosis.99
Canine brain tissue has been subjected to 2DE and
MALDI-TOF MS in a model of Alzheimer disease where envi-
ronmental enrichment and antioxidant-fortified food were
compared to controls.90 The group with both treatments
showed the best neuronal function and cognition and, upon pro-
teomic analysis, was shown to differ from the control group in
reduced expression of parietal cortex proteins, including gluta-
mate dehydrogenase, enolase, and glutathione-S-transferase,
while creatine kinase and glyceraldehyde-3 phosphate dehy-
drogenase, among other proteins, were upregulated.
Using iTRAQ and LC-MS/MS technology, the proteins in
early- and late-stage myxomatous mitral valve disease in dogs
have been examined,69 with 117 proteins identified in mitral
valves that were differentially expressed as compared to tissue
from healthy dogs. Based on hierarchical sample clustering, it
was evident that the altered expression of the mitral proteins
occurred in the early stage of disease progression, thereby pro-
viding a valuable model of the equivalent human disease.
Finally, canine liver has been examined in bull terriers with
a genetic disorder leading to inherited lethal acrodermatitis,49
which may be particularly interesting on the background of the
possible utilization of dogs as model for equivalent human dis-
ease. In this study, 13 differently expressed proteins were iden-
tified, involved in processes such as chaperone action, calcium
binding, and energy metabolism.
Proteomics and Posttranslational
Modifications in Veterinary Diagnostics
Changes in posttranslational modification readily occur in
inflammation but also in cancer and other disease states. Based
on recent advances in the development of analytic techniques
and instrumentation, MS in particular, several blood-derived
glycan-based biomarkers using glycomics strategies have been
identified.1,5,98 Due to the high extent of its carbohydrate moi-
ety (more than 40% of the weight of the protein), the acute-
phase protein alpha1 acid glycoprotein (AGP) has been rightly
regarded as a model to study posttranslational modifications
during diseases23 and an ideal model to implement these find-
ings as a biomarker source. In fact, AGP glycan pattern has
been found to be modified in animal diseases, as well in
cats24,93 and goats.25 Furthermore, a proteomic approach has
been utilized to determine the differences between AGP glyco-
forms from different tissue origins, which is one of the first
steps to utilize AGP as specific biomarker for diseases.24 Struc-
tural modifications of other proteins, such as transthyretin, in
animals have been described as well, including horses54 and
apes.100 A proteome-wide glycan analysis was carried out in
dog serum though a lectin-enrichment-based approach coupled
with MS, which allowed high-throughput investigation of pro-
tein glycosylation signatures.28 While application of glycomics
is still quite far from the veterinary field, posttranslational mod-
ification of proteins occurin in neoplastic disease may provide
further opportunities to identify biomarkers of the disease in
animals. Glycoproteomic profile of serum peptides has been
examined by a combination of lectin affinity selection, global
internal standard technology, high-performance LC, and
MALDI-TOF to investigate canine lymphoma and transitional
cell carcinoma.115 Two peptides were identified that allowed
discrimination between these conditions.
Immunoproteomics: Identifying Antigens
Involved in Immune Response Against
Pathogens
The immunoproteome defines the subset of proteins that
induce immune response. Circulating serum antibodies repre-
sent important biomarkers per se, since their half-life varies
between 7 and 20 days and they are highly stable compared
to other serum proteins. The aim of immunoproteomics is to
identify the antigens that these circulating antibodies have
been raised against during a given infectious disease.
Immunoproteomic-based available techniques include gel-
based and gel-free immunoproteomics.
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Gel-based immunoproteomics relies on the separation of a
complex mixture of proteins derived from pathogens by 2DE
and electrotransfer onto a solid support, usually nitrocellulose.
Immunoreactive proteins are then identified after incubation of
the membrane with serum from infected animals. Gel-based
immunoproteomic techniques have been widely utilized in
veterinary immunoproteomics to identify, for example, specific
antigens involved in paraTBC73 in both cattle and sheep,60
Streptococcus suis in pig,119 and Staphylococcus aureus iso-
lated from bovine mastitis.107 Immunoreactants against para-
sites were characterized as well, such as those from Fasciola
hepatica and Schistosoma mansoni16 in cattle and Haemoncus
contortus in sheep.118
Gel-free immunoproteomics takes advantage of different
physicochemical characteristics of antigens, such as isoelectric
point, hydrophobicity, and/or affinity with immune sera to sort
complex mixtures in smaller groups of proteins. Protein subfrac-
tions are then identified by MS. Immunoproteomics of Brucella
abortus identified differential immunoreactivity of Triton
X-114-soluble antigens between naturally infected vaccinated
and nonvaccinated seronegative cows, identifying antigens
potentially useful for immunoassays. In a very elegant experi-
ment, Neospora caninum antigens were identified after their
interaction with CD4þ T-cell lines.95 In a first step N. caninum
tachyzoite water-soluble antigens were grossly fractionated by
size exclusion chromatography. Their immune-stimulating capa-
bility was then assessed after challenging CD14þ T-cell lines
with sorted protein groups, and the immunologic selected
fractions were eventually analyzed by LC-ESI-MS/MS.
Clinical Proteomics: Biomarker Discovery
While single-protein concentration assessed by antibody-based
affinity is still the gold standard of diagnostics for clinical prac-
tice, there is now a general agreement that a panel of indepen-
dent disease-related proteins could substantially improve the
diagnosis of animal diseases. High-throughput proteomics has
emerged as the most powerful technique for identifying protein
profiles in animal biological fluids, as shown in Table 1. The
application of proteomics as a diagnostic tool has been further
implemented by its capability to analyze new and ‘‘neglected’’
biological fluids, such as saliva70 or tears,102 to complement the
classic fluids (ie, blood serum and milk). The identification of
markers related to diseases has wide practical implications,
since they provide diagnostic tools as well as potential targets
for novel approaches to monitor the therapies. Notwithstanding
its progress, the translation of biomarkers from the discovery
field to their clinical use is still hampered by several pitfalls,
which are particularly evident in veterinary medicine,
including
Sample collection—since differences among age, breeds, but
also sample collection and storage (ie, the amount of time
between sample draw and analysis) may profoundly alter
serum protein profiles.30
Dynamic range—serum/plasma is the most important clini-
cal specimen, but no more than 10 proteins make up
90% of the total protein serum content, more than half
being made of albumin. There are therefore at least 10
orders of magnitude difference between the highest- and
lowest-abundant protein. These potential obstacles can
be overcome by using depletion of most abundant pro-
teins by beads (Proteo Miner)78 or by immunodepletion.44
However, several potentially important proteins may be
lost in the process due to their bonding to removed
high-abundant proteins.
Cost—which is unaffordable for veterinary clinical practice
at this stage, though it may be reduced in the future.
Therefore, while proteomics has been extremely useful so far
for new potential biomarker discovery, further work is required
to standardize routine utilization in veterinary practice.
Histoproteomics: The Application of
Proteomics to Tissues Processed for
Immunohistochemistry
Standard techniques for preserving biological material for stor-
age and histologic processing include snap freezing in liquid
nitrogen and fixation in formalin and embedding in paraffin
(FFPE). Proteomic techniques have been developed to investi-
gate the localization and expression profiles of proteins on
freshly frozen pathologic specimens, meanwhile preserving the
histolopathologic integrity of the tissues. LC-MS workflows
have been optimized to determine laser-captured microdis-
sected pathologic tissues and have been applied to specimens
from human breast cancer tissues,17 fixed with ice-cold ethanol
(70%), and then stained with hematoxylin. Laser-capture dis-
section was then carried out on stained tissues, and more than
400 proteins were identified by LC, followed by MS. General
application of such optimized protocols to animal disease diag-
nosis has been prevented, at least so far, by economic reasons.
Nonetheless, as such protocols are now available, its future
application in veterinary clinical practice or research can be
envisaged. Cryopreserved samples provide the first choice for
proteomic analyses, since proteins are not modified. It must
also be said that morphologic details are not optimally pre-
served. Moreover, longtime storage is expensive and may not
be accurate.
Embedding of samples in paraffin after formalin fixation
represents a serious challenge for protein extraction. Formalin
reaction with tissues results in the cross-linking between pro-
teins, causing a significant reduction of recovery. New
formalin-free fixatives that may enable both histologic and
molecular analyses are now available, and their potential value
for proteomic investigation has been assessed.43,67 These new
methods have proven very effective in proteomics on archived
cancer tissues.13 While providing useful protocols for future
applications of proteomic techniques to novel processed patho-
logic specimens, protocols to extract and analyze proteins from
FFPE are mostly required to take advantage from the huge
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histologic and pathologic archives available, which represent
the most abundant and already classified pathologic specimens,
allowing retrospective analysis, with extended and well-
documented clinicopathological follow-up. FFPE tissues still
provide major challenges to proteomics. Protein extraction
issues from FFPE tissues has been recently reviewed.113 Appli-
cation of 2-dimensional DiGE on FFPE specimens was suc-
cessfully carried out on dog and sheep tissues,105,106 after
deparaffination with xylene. Current protocols have to be
improved: only low molecular weight peptides were success-
fully removed, and the yield was low. High molecular weight
proteins were poorly resolved due to high background, making
their identification difficult. Nonetheless, these results provide
a valuable starting point and demonstrated for the first time
how proteomic techniques can be effectively applied on stored
tissues of veterinary interest.
Final Remarks and Future Perspectives
Better biomarkers are urgently needed in veterinary medicine
for diagnosis and prognosis of diseases. The research world
is entering a postgenomic era, which provides great opportuni-
ties in the pursuit of new biomarkers. Proteomics in veterinary
science is still lagging, if compared with proteomics in humans
and mice. It is clear that valuable information on the molecular
mechanism of diseases of animals of veterinary interest is
being and will be generated in the future as the technology
becomes more applicable in studies designed to explore and
explain the pathology of veterinary disease. Initial proteomic
studies, when applied to novel areas, have tended to focus at
first on describing the proteome of a particular tissue or fluid.
Then the power of the techniques is recognized, and experi-
ments to compare and quantify protein changes in experimental
procedure or in comparison of disease to healthy samples
become more common. The application of proteomics in the
study of veterinary pathology is entering this second stage.
One of the reasons why proteomics has played a limited role
in veterinary medicine and diagnostics, beside the economic
one, is the scarce genomic and proteomic data available as
compared with rodents and humans. The recent publication
of genomes from pig and cow as well as the growing availabil-
ity of proteomic reference maps of companion animal tissues
and biological fluids will probably overcome these technical
barriers. The cost of proteomics experiments is decreasing as
well. Given these premises, the still-limited number of proteo-
mic maps is expected to increase, providing new opportunities
to utilize proteomic information for diagnosis of animal dis-
eases. Technological advances in proteomics, such as those
briefly described in the present review, have expanded the
dynamic range of detection for low-abundance proteins, allow-
ing the detection of disease-specific proteins to be used as
potential biomarkers in veterinary medicine as well. The ulti-
mate goal should be to develop diagnostic protocols on clinical
samples at multiple levels, including transcriptome (RNA) and
proteome (proteins). The development of techniques allowing
extraction of molecular information from FFPE tissue, coupled
with bioinformatics tools, will provide further advances in the
identification of reliable biomarkers through accessing
the extensive archives of annotated tissue samples, which can
be linked to clinical information and disease outcome.
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